InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Buten Matthew. Director active across 2 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. Cumulatively, 7 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €2m. History available since 31 December 2021. The latest transaction was disclosed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Buten Matthew is a declarant linked to Biohaven Ltd. and Biohaven Pharmaceutical Holding Co Ltd., where he is Chief Financial Officer. His 7 filings cover the period from 2022-01-04 to 2026-01-07, and, across the sampled recent filings, the stated amounts are EUR 1979538 of buys and EUR 932952 of sells, with Levée d'options as the most frequent transaction nature.